BreachRx offers a secure, central workspace that enables real-time, cross-functional collaboration during cybersecurity incidents by defining roles, responsibilities, timelines, and workflows. Its platform automatically generates tailored incident response playbooks, provides targeted guidance to stakeholders, and includes integrated privileged communication channels and audit trails. The company markets patented technology designed to bring operational resilience before, during, and after incidents, and to produce reports for boards, auditors, and regulators. BreachRx has achieved more than 3x year-over-year ARR growth for the second consecutive year and currently serves more than 100 customers, including publicly traded and Fortune 500 companies across financial services, technology, healthcare, and critical infrastructure. The team plans to use new funding to scale go-to-market and engineering teams to accelerate adoption and product innovation. Andy Lunsford (CEO and co-founder) and Matt Hartley (co-founder) lead the company from its San Francisco base. BreachRx offers a patented intelligent incident response platform that automatically generates tailored incident response plans and delivers targeted guidance to relevant stakeholders through every step of a breach. The platform includes integrated privileged communication channels and audit trails to ensure compliance with evolving regulations. It is positioned to proactively protect CISOs and executive leadership from personal liability. BreachRx serves more than 70 customers, including publicly traded and Fortune 500 companies. The company announced executive and board additions, including former Uber CSO Joe Sullivan as senior advisor, Tim McKnight (SYN Ventures) to the board, and Art Coviello as board observer. BreachRx is based in San Francisco and plans to use new funding to scale its go-to-market and engineering teams.

Total raised

$22M

Funding rounds

2

Latest round

Series A

Latest activity

May 2025